Breast imaging Market Trends

ID: MRFR/HC/4163-CR

200 Pages

Rahul Gotadki

July 2025

Breast Imaging Market Research Report: Size, Share, Trend Analysis By Technology (Mammography, Ultrasound, Magnetic Resonance Imaging, Tomosynthesis, Breast Biopsy), By Product (Systems, Consumables, Software), By Applications (Screening, Diagnosis, Treatment Planning), By End Use (Hospitals, Diagnostic Centers, Research Institutes) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast Till 2035

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Breast imaging Market

Effective treatment for breast cancer is more likely when the disease is detected early. According to the American Cancer Society, if breast cancer is identified early and at the localized stage, the five-year relative survival rate is an impressive 99 percent, as of January 2021. Unfortunately, many cases of breast cancer are diagnosed late, often due to a lack of awareness about early diagnosis and screening methods, especially in developing countries. This emphasizes the importance of increasing awareness about the benefits of early cancer detection.

To promote early breast cancer diagnosis, various government and organization-led programs have been established. For example, the Netherlands has the National Breast Cancer Screening Programme, designed for women aged 50 to 75. Women in this age group are invited for a mammogram once every two years as part of this program. Similarly, in Australia, the government runs a program where women aged 50 to 74 are invited to receive free mammograms every two years through the national screening program called Breast Screen Australia. Additionally, in the US, the National Breast Cancer Foundation, Inc., a non-governmental organization (NGO), organizes the National Mammography Program annually. This program provides free mammograms and diagnostic services to facilitate early detection and treatment. As a result, the increasing demand for early breast cancer diagnosis is expected to propel market growth in the forecast period.

It's crucial to understand that early detection can significantly improve the chances of successful treatment for breast cancer. Awareness initiatives and screening programs play a pivotal role in educating individuals about the importance of early diagnosis and providing accessible avenues for screenings. The emphasis on these programs not only helps in identifying cases at an early, more treatable stage but also contributes to overall public health by reducing the burden of advanced-stage cancer cases.

Moreover, the success of these programs is contingent on widespread awareness and participation. Efforts to educate communities, especially in regions where awareness is lacking, become integral. This involves not only informing individuals about the availability and benefits of screenings but also addressing any misconceptions or fears associated with the process. Cultivating a culture of proactive health management and regular screenings is essential in the fight against breast cancer.

In conclusion, the push for early breast cancer diagnosis is a critical aspect of improving survival rates and reducing the impact of the disease on individuals and communities. Government and NGO-led programs play a vital role in making screenings accessible to a broader population. As awareness continues to grow and more individuals prioritize early detection, the market for breast cancer diagnosis is expected to witness sustained growth, ultimately contributing to better health outcomes for affected individuals.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected growth of the Breast Imaging market?

The Breast Imaging market is the expected increase in total market value of 11.94 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Breast Imaging market?

Breast Imaging market size was valued at approximately 4.96 billion USD in 2024. This figure will reach 11.94 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Breast Imaging market?

Breast Imaging market is expected to grow at a CAGR of 8.32% between 2025 and 2035.

How much will the Breast Imaging market be worth by 2035?

Breast Imaging market is expected to be worth of 11.94 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Breast Imaging market perform over the next 10 years?

Over the next 10 years the Breast Imaging market is expected to shift from usd billion 4.96 to 11.94 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

Which region held the largest market share in the Breast Imaging Market by 2035?

North America held the largest market share at 2.7 USD Billion by 2035.

What will be the market value for the Mammography segment in 2024?

The Mammography segment is projected to be valued at 2.031 billion USD by 2035.

What was the market size for the Ultrasound segment in 2024?

The Ultrasound segment was valued at 0.655 billion USD in 2024. of the Breast Imaging Market is valued at 1.08 USD Billion in the year 2024

How much is the Ultrasound segment projected to grow by 2035?

The Ultrasound segment is projected to grow to 1.179 USD Billion by 2035.

Who are the key players in the Breast Imaging Market?

Some of the major players in the market include GE Healthcare, Hologic, Siemens Healthineers, and Canon Medical Systems.

What will the market size be for the APAC region in 2024?

The Asia Pacific region is expected to have a market value of 0.75 USD Billion in 2024.

What growth opportunities exist for the Breast Imaging Market?

There are significant growth opportunities driven by technological advancements and increasing awareness in breast health.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Breast imaging Market Size was estimated at 4956.71 USD Million in 2024. The Breast imaging industry is projected to grow from 5369.12 in 2025 to 11939.86 by 2035, exhibiting a compound annual growth rate (CAGR) of 8.32 during the forecast period 2026 - 2035.

Key Market Trends & Highlights

The Breast Imaging Market is experiencing robust growth driven by technological advancements and increasing awareness.

Technological advancements in imaging techniques are enhancing diagnostic accuracy and patient outcomes. North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in breast imaging. The screening segment dominates the market, whereas the diagnosis segment is witnessing the fastest growth due to rising demand for early detection. Key market drivers include the rising incidence of breast cancer and increased focus on preventive healthcare initiatives.

Market Size & Forecast

2024 Market Size	4956.71 (USD Million)
2035 Market Size	11939.86 (USD Million)
CAGR (2025 - 2035)	8.32%
Largest Regional Market Share in 2024	North America

Major Players

Hologic (US), Siemens Healthineers (DE), GE Healthcare (US), Philips (NL), Canon Medical Systems (JP), Fujifilm (JP), Carestream Health (US), Konica Minolta (JP), Agfa HealthCare (BE)

Market Trends

The Breast imaging Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing emphasis on early detection of breast cancer. Innovations such as digital mammography, breast MRI, and ultrasound imaging are becoming more prevalent, enhancing diagnostic accuracy and patient outcomes. Furthermore, the integration of artificial intelligence in imaging processes appears to streamline workflows and improve interpretation efficiency. As healthcare systems worldwide prioritize preventive care, the demand for sophisticated imaging solutions is likely to rise, fostering a competitive landscape among manufacturers and service providers. In addition to technological advancements, the Breast imaging Market is influenced by growing awareness regarding breast health among women. Educational initiatives and campaigns aimed at promoting regular screenings are contributing to a cultural shift towards proactive health management. This heightened awareness may lead to increased patient engagement and a greater willingness to undergo imaging procedures. Consequently, stakeholders in the market are focusing on developing user-friendly devices and enhancing accessibility to cater to diverse populations, ensuring that quality breast imaging services are available to all women, regardless of geographical or socioeconomic barriers.

Technological Advancements

The Breast imaging Market is witnessing rapid technological progress, with innovations such as digital mammography and advanced ultrasound techniques enhancing diagnostic capabilities. These developments not only improve image quality but also facilitate earlier detection of abnormalities, potentially leading to better patient outcomes.

Increased Awareness and Education

There is a notable rise in awareness regarding breast health, driven by educational campaigns and advocacy efforts. This trend encourages women to prioritize regular screenings, thereby increasing the demand for breast imaging services and fostering a culture of proactive health management.

Integration of Artificial Intelligence

The incorporation of artificial intelligence into breast imaging processes is transforming the landscape. AI algorithms are being utilized to assist radiologists in interpreting images more accurately and efficiently, which may lead to reduced diagnostic errors and improved workflow in clinical settings.

Breast imaging Market Market Drivers

Market Growth Projections

The Global Breast Imaging Market Industry is projected to experience substantial growth over the next decade. With a market value of 3.37 USD Billion in 2024, it is anticipated to reach 5.5 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 4.55% from 2025 to 2035. Such projections indicate a robust demand for breast imaging solutions driven by various factors, including technological advancements, increasing breast cancer incidence, and heightened awareness of preventive healthcare. The market's expansion reflects the ongoing commitment to improving breast health outcomes globally.

Growing Awareness and Education

The rising awareness regarding breast health and the importance of regular screenings is a crucial driver for the Global Breast Imaging Market Industry. Educational campaigns by health organizations and non-profits are effectively informing women about the benefits of early detection. This heightened awareness is leading to increased participation in screening programs, thereby driving demand for breast imaging services. As more women understand the risks associated with breast cancer, the likelihood of seeking preventive care rises. Consequently, the market is poised for growth, with projections indicating a significant increase in revenue as more individuals prioritize their health and well-being.

Rising Incidence of Breast Cancer

The increasing prevalence of breast cancer globally is a primary driver of the Global Breast Imaging Market Industry. According to credible health organizations, breast cancer remains one of the most commonly diagnosed cancers among women, with millions of new cases reported annually. This alarming trend necessitates advanced imaging technologies for early detection and diagnosis, thus propelling market growth. In 2024, the market is projected to reach 3.37 USD Billion, reflecting the urgent need for effective screening methods. As awareness campaigns and screening programs expand, the demand for breast imaging solutions is likely to rise, further contributing to the industry's expansion.

Government Initiatives and Funding

Government initiatives aimed at improving breast cancer screening and treatment are significantly influencing the Global Breast Imaging Market Industry. Many countries are implementing national screening programs and allocating funds to enhance healthcare infrastructure. For example, public health campaigns that promote regular mammography screenings have been shown to increase early detection rates. Such initiatives not only raise awareness but also stimulate demand for advanced imaging technologies. As governments continue to prioritize women's health, the market is expected to grow steadily, with a projected CAGR of 4.55% from 2025 to 2035, reflecting the ongoing commitment to improving breast cancer outcomes.

Technological Advancements in Imaging Techniques

Innovations in breast imaging technologies, such as digital mammography, 3D tomosynthesis, and MRI, are transforming the Global Breast Imaging Market Industry. These advancements enhance diagnostic accuracy and patient comfort, leading to increased adoption among healthcare providers. For instance, 3D mammography has been shown to improve cancer detection rates while reducing false positives. As these technologies become more accessible and affordable, healthcare facilities are likely to invest in upgrading their imaging capabilities. This trend is expected to drive market growth, with projections indicating a rise to 5.5 USD Billion by 2035, underscoring the importance of continuous innovation in the field.

Integration of Artificial Intelligence in Imaging

The integration of artificial intelligence (AI) into breast imaging technologies is reshaping the Global Breast Imaging Market Industry. AI algorithms are being developed to assist radiologists in interpreting mammograms and identifying potential abnormalities with greater accuracy. This technological synergy not only enhances diagnostic precision but also streamlines workflow in clinical settings. As healthcare providers increasingly adopt AI-driven solutions, the efficiency and effectiveness of breast imaging are likely to improve. This trend may contribute to the market's expansion, as facilities seek to leverage cutting-edge technologies to provide better patient care and outcomes.

Market Segment Insights

By Application: Screening (Largest) vs. Diagnosis (Fastest-Growing)

In the Breast Imaging Market, the application segments are diverse, comprising screening, diagnosis, monitoring, research, and therapeutic methods. Among these, screening holds the largest market share, emphasizing its critical role in early detection and prevention of breast cancer. The emphasis on regular screenings in various healthcare policies and initiatives has significantly bolstered its market position and share. Conversely, the diagnosis segment is gaining momentum as the fastest-growing area, driven by technological advancements and a growing need for accurate and immediate diagnosis following abnormal screening results.

Screening (Dominant) vs. Diagnosis (Emerging)

The screening segment in breast imaging employs techniques such as mammography and ultrasound, making it a dominant player in the market due to its role in preventive healthcare. It has established protocols and guidelines that encourage regular check-ups, ultimately fostering a proactive approach to breast health. On the other hand, the diagnosis segment, characterized by innovations like digital breast tomosynthesis and MRI, is regarded as an emerging powerhouse. Its growth is fueled by advancements in imaging technologies and increasing awareness among patients and healthcare providers for precise evaluations following initial screenings.

By Technology: Mammography (Largest) vs. Tomosynthesis (Fastest-Growing)

In the Breast Imaging Market, Mammography has maintained its position as the largest segment, owing to its widespread adoption and established protocols in breast cancer screening. Meanwhile, Tomosynthesis has emerged as a promising technology that offers enhanced imaging capabilities, allowing for better detection rates and improved diagnostic outcomes. The market share distribution reflects a strong preference for these technologies among healthcare providers and patients alike, with Mammography leading the charge while newer modalities like Tomosynthesis gain traction.

Technology: Mammography (Dominant) vs. Tomosynthesis (Emerging)

Mammography stands as the dominant force in breast imaging, characterized by its effectiveness in detecting early-stage breast cancer through standard two-dimensional images. The technology is widely recognized and recommended by health organizations, making it a staple in screening programs. In contrast, Tomosynthesis, recognized as an emerging technology, provides 3D imaging that reduces false positives and allows for better visualization of overlapping tissues. This advancement positions Tomosynthesis as a favorable choice for clinicians aiming for enhanced diagnostic precision, indicating a shift in preference within the market as practitioners seek innovative solutions to improve patient outcomes.

By End Use: Hospitals (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing)

In the Breast Imaging Market, hospitals account for the largest share due to their comprehensive facilities, integration of advanced technologies, and higher patient footfall. As primary providers of breast imaging services, hospitals benefit from significant investments in specialized imaging equipment and trained personnel. On the other hand, diagnostic imaging centers are emerging rapidly, catering to a specific segment of patients seeking quicker and more accessible imaging solutions, thus capturing a notable market share in recent years. The growth of the end-use segment is driven by the increasing incidence of breast cancer and the rising awareness of early detection. Innovations in imaging technologies and an expanding patient base seeking outpatient care further contribute to the growth of diagnostic imaging centers. Additionally, the shift towards preventive healthcare and home care models is influencing these segments positively, making them critical players in the overall breast imaging landscape.

Hospitals: Dominant vs. Outpatient Clinics: Emerging

Hospitals serve as the dominant segment in the Breast Imaging Market, characterized by their extensive infrastructure and multidisciplinary approach to patient care. They invest heavily in state-of-the-art imaging technology, including digital mammography and breast MRI, which enhances diagnostic accuracy. Moreover, hospitals leverage the expertise of specialized oncologists and radiologists, ensuring comprehensive treatment options alongside imaging services. Conversely, outpatient clinics are emerging as an appealing alternative, focusing on convenience and patient-centric services. They offer shorter wait times and flexible scheduling, appealing to a growing demographic seeking timely imaging services. As more patients opt for outpatient services, clinics are expanding their offerings to include advanced imaging technologies, thereby positioning themselves competitively in the market.

Get more detailed insights about Breast Imaging Market Research Report-Forecast till 2035

Regional Insights

North America : Market Leader in Innovation

North America continues to lead the breast imaging market, holding a significant share of approximately 58.5% with a market size of $2478.36M. The growth is driven by advanced healthcare infrastructure, increasing awareness of breast cancer, and supportive government regulations promoting early detection. The region's focus on technological advancements, such as 3D mammography and AI integration, further fuels demand. The United States is the primary contributor, with key players like Hologic, GE Healthcare, and Siemens Healthineers dominating the landscape. The competitive environment is characterized by continuous innovation and strategic partnerships aimed at enhancing diagnostic accuracy. The presence of established healthcare systems and funding for research and development solidifies North America's position as a leader in breast imaging.

Europe : Emerging Market with Growth Potential

Europe's breast imaging market is poised for growth, with a market size of $1450.0M, accounting for approximately 29.3% of the global share. Factors such as rising breast cancer incidences, increased healthcare spending, and regulatory support for screening programs are driving this expansion. The European Union's initiatives to standardize breast cancer screening further enhance market dynamics, promoting early detection and treatment. Leading countries include Germany, France, and the UK, where major players like Siemens Healthineers and Philips are actively innovating. The competitive landscape is marked by collaborations between healthcare providers and technology firms, aiming to improve imaging techniques. The presence of robust healthcare policies and funding for medical technologies positions Europe as a significant player in the breast imaging market.

Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific breast imaging market is rapidly expanding, with a market size of $850.0M, representing a growing share of the global market. Key growth drivers include increasing awareness of breast cancer, rising disposable incomes, and government initiatives to improve healthcare access. The region is witnessing a shift towards advanced imaging technologies, such as digital mammography and ultrasound, which are becoming more accessible. Countries like Japan, China, and India are leading the charge, with significant investments in healthcare infrastructure. Major players such as Fujifilm and Canon Medical Systems are enhancing their presence through strategic partnerships and product innovations. The competitive landscape is evolving, with a focus on affordability and accessibility, making breast imaging services more available to the population.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa (MEA) breast imaging market is at a nascent stage, with a market size of $178.35M, accounting for a smaller share of the global market. The growth is hindered by limited healthcare infrastructure and awareness about breast cancer. However, increasing government initiatives and international collaborations are paving the way for improvements in screening and diagnostic services, which are crucial for early detection. Countries like South Africa and the UAE are making strides in enhancing breast imaging capabilities. The presence of key players such as Agfa HealthCare and Carestream Health is vital for introducing advanced technologies. The competitive landscape is characterized by a focus on education and awareness campaigns to promote breast health, which is essential for market growth in this region.

Key Players and Competitive Insights

The Breast imaging Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing awareness of breast cancer screening, and a growing emphasis on early detection. Major players such as Hologic (US), Siemens Healthineers (DE), and GE Healthcare (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Hologic (US) focuses on innovation in 3D mammography and breast biopsy technologies, while Siemens Healthineers (DE) emphasizes digital transformation and AI integration in imaging solutions. GE Healthcare (US) is leveraging partnerships to expand its product offerings and improve accessibility in emerging markets, collectively shaping a competitive environment that prioritizes technological sophistication and patient-centric solutions.Key business tactics within the Breast imaging Market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and services, catering to varying consumer needs and preferences. The collective strategies of these companies indicate a trend towards collaboration and innovation, which is likely to intensify competition.

In November Hologic (US) announced a strategic partnership with a leading telehealth provider to enhance remote screening capabilities. This move is significant as it aligns with the growing demand for accessible healthcare solutions, particularly in underserved regions. By integrating telehealth services with its advanced imaging technologies, Hologic (US) positions itself to capture a larger share of the market while addressing the critical need for early detection.

In October Siemens Healthineers (DE) launched a new AI-driven software platform designed to improve diagnostic accuracy in breast imaging. This initiative underscores the company's commitment to digital innovation and reflects a broader industry trend towards integrating AI into healthcare solutions. The introduction of this platform is expected to enhance workflow efficiency and diagnostic precision, thereby reinforcing Siemens Healthineers' competitive edge.

In September GE Healthcare (US) expanded its product line by introducing a new portable breast imaging device aimed at improving access in rural areas. This strategic move not only addresses the accessibility challenge but also demonstrates GE Healthcare's focus on innovation and adaptability in response to market demands. The portable device is anticipated to facilitate early detection, ultimately contributing to better patient outcomes.

As of December current competitive trends in the Breast imaging Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, enabling companies to pool resources and expertise to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, reliability in supply chains, and the ability to deliver comprehensive, patient-centered solutions. This shift suggests that companies prioritizing innovation and strategic partnerships will be better positioned to thrive in the evolving landscape.

Key Companies in the Breast imaging Market include

Industry Developments

In recent months, the Breast Imaging Market has experienced significant developments, particularly with advancements in technology and product launches. Companies such as Hologic and Siemens Healthineers are leading the way by introducing state-of-the-art imaging systems that enhance diagnostic accuracy.

Notably, in September 2023, Konica Minolta unveiled its new 3D breast imaging technology, which has generated considerable interest in clinical settings. Additionally, a notable acquisition took place in March 2023 when Fujifilm acquired the breast imaging business of Carestream Health, marking a strategic move to broaden its diagnostic portfolio.

This acquisition has been well-received within the industry, reinforcing Fujifilm's market presence. Over the last couple of years, there has been a steady growth in the valuation of companies within this sector, driven largely by the rising incidence of breast cancer and an increasing focus on early detection methods.

As healthcare professionals seek more accurate imaging solutions, the collaboration between these prominent companies like Canon Medical Systems, Trivitron Healthcare, and General Electric continues to foster innovation, further enhancing patient care on a global scale.

Future Outlook

Breast imaging Market Future Outlook

The Breast Imaging Market is projected to grow at an 8.32% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and rising incidence of breast cancer.

New opportunities lie in:

Expansion of AI-driven diagnostic tools for enhanced accuracy Development of portable imaging devices for remote areas Integration of telehealth services for improved patient access

By 2035, the Breast Imaging Market is expected to be robust, driven by innovation and increased demand.

Market Segmentation

Breast imaging Market End Use Outlook

Hospitals
Diagnostic Imaging Centers
Research Institutions
Outpatient Clinics
Home Care

Breast imaging Market Technology Outlook

Mammography
Ultrasound
Magnetic Resonance Imaging
Tomosynthesis
Positron Emission Tomography

Breast imaging Market Application Outlook

Screening
Diagnosis
Monitoring
Research
Therapeutic

Report Scope

MARKET SIZE 2024	4956.71(USD Million)
MARKET SIZE 2025	5369.12(USD Million)
MARKET SIZE 2035	11939.86(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	8.32% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2026 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Million
Key Companies Profiled	Hologic (US), Siemens Healthineers (DE), GE Healthcare (US), Philips (NL), Canon Medical Systems (JP), Fujifilm (JP), Carestream Health (US), Konica Minolta (JP), Agfa HealthCare (BE)
Segments Covered	Application, Technology, End Use
Key Market Opportunities	Integration of artificial intelligence in Breast imaging Market enhances diagnostic accuracy and operational efficiency.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the breast imaging market.
Countries Covered	North America, Europe, APAC, South America, MEA